HELIOS Action: Advancing research, education, and equity in hemoglobinopathies across Europe and beyond
Sotiroula Chatzimatthaiou(Cyprus Institute of Neurology and Genetics), Petros Kountouris(Cyprus Institute of Neurology and Genetics), Baba Inusa(St Thomas' Hospital), Eleni Gavriilaki(Aristotle University of Thessaloniki), Fedele Bonifazi(Gianni Benzi Pharmacological Research Foundation), Annalisa Landi(Fondazione per la Ricerca Farmacologica Gianni Benzi Onlus), Darko Antić(University of Belgrade), Francesco Cremonesi(Observatoire de la Côte d’Azur), Holger Cario(Universität Ulm), Joanne Traeger‐Synodinos(National and Kapodistrian University of Athens), Elisabetta Mezzalira(University of Padua), M Pellégrini(SEW Eurodrive (Germany)), Anna Collado Gimbert(Vall d'Hebron Institut de Recerca), Raffaella Colombatti(University of Padua), Carsten W. Lederer(Cyprus Institute of Neurology and Genetics), Andreas Glenthøj(University of Copenhagen), Burak Durmaz(Ege University), María Del Mar Mañú Pereira(Vall d'Hebron Institut de Recerca), Francesca Basile(Fondazione per la Ricerca Farmacologica Gianni Benzi Onlus), Eleni Katsantoni(Academy of Athens), Dilem Ruhluel(Cyprus Institute of Neurology and Genetics), Coralea Stephanou(Agruicultural Research Institute)
Cited by 6
Related Papers
Structural and non-coding variants increase the diagnostic yield of clinical whole genome sequencing for rare diseases
|Genome Medicine|2023|71
Evans syndrome in adults: an observational multicenter study
|Blood Advances|2021|70